MAPT and Alzheimer disease: Beyond candidates, pleiotropy-informed GWAS identify shared HLA architecture (rs2516049 near HLA-DRB5) with concordant effects on psoriasis and AD and correlations with tau pathology and cognitive decline, implicating antigen presentation in both skin and brain [43].